In the article titled "Propofol Attenuates Small Intestinal Ischemia Reperfusion Injury through Inhibiting NADPH Oxidase Mediated Mast Cell Activation" \[[@B1]\], the *α*-tubulin samples in Figures 5(g) and 5(h) should have included nine samples; however, due to an error during the production process, only seven samples appeared. Also, the legends of figures 5A and 5B were reversed. The corrected figures and legend are as follows.

![Changes of SOD activities, 15-F~2t~-isoprostane contents, p47^phox^ protein expression, gp91^phox^, P-selectin, and ICAM-1 protein expressions, IL-6 levels, and MPO activities in intestine mucosa after IIR injury. SHAM group (Sham-operated group), IIR group (75 min intestinal ischemia and 2 h reperfusion), and IIR + CP group (IIR group + compound 48/80 1 mg/kg) in the absence or presence of NAC (0.5 g/kg), propofol (50 mg/kg), intralipid (50 mg/kg). (a) 15-F~2t~-isoprostane contents in intestine (*n* = 6, except *n* = 4 in IIR + CP group). (b) SOD activities (c) and (d) p47^phox^ and gp91^phox^ protein expressions, respectively (*n* = 3), (e) and (f) IL-6 levels and MPO activities in intestinal mucosa (*n* = 6, except *n* = 4 in IIR + CP group). (g) and (h) ICAM-1 and P-selectin protein expressions, respectively (*n* = 3). Results are expressed as mean ± SEM. ^∗^*P* \< 0.05 versus SHAM group, ^\#^*P* \< 0.05 versus IIR group, ^\$^*P* \< 0.05 versus IIR + CP group, ^&^*P* \< 0.05 versus IIR with NAC pretreated group, ^△^*P* \< 0.05 versus IIR with propofol pretreated group, and ^▲^*P* \< 0.05 versus IIR with intralipid pretreated group.](OMCL2017-8932871.001){#fig1}
